COPD Exacerbation Treatment vs PSA (Prostate-Specific Antigen)
Medicare Cost Comparison 2025
Quick Answer
COPD Exacerbation Treatment: $12,000 total · Medicare pays $9,600 · Patient pays $2,400
PSA (Prostate-Specific Antigen): $40 total · Medicare pays $32 · Patient pays $8
Cost Comparison
| Metric | COPD Exacerbation Treatment | PSA (Prostate-Specific Antigen) |
|---|---|---|
| Total Average Cost | $12,000 | $40 |
| Medicare Pays | $9,600 | $32 |
| Patient Pays | $2,400 | $8 |
| Category | hospital | lab |
FAQ
What is the cost difference between COPD Exacerbation Treatment and PSA (Prostate-Specific Antigen)?
COPD Exacerbation Treatment costs $12,000 on average, while PSA (Prostate-Specific Antigen) costs $40 — a difference of $11,960.
How much does Medicare pay for COPD Exacerbation Treatment vs PSA (Prostate-Specific Antigen)?
Medicare typically pays $9,600 for COPD Exacerbation Treatment (patient owes $2,400). For PSA (Prostate-Specific Antigen), Medicare pays $32 (patient owes $8).
What is COPD Exacerbation Treatment?
Hospital treatment for acute worsening of chronic obstructive pulmonary disease.
What is PSA (Prostate-Specific Antigen)?
Blood test for prostate cancer screening.